BRISBANE, Calif., May 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- InterMune, Inc. (Nasdaq: ITMN) announced today that it has hired Fred J. Schreiber as the Company's new Senior Vice President of Human Resources, and Malcolm McKay, Ph.D., to the newly created position of Vice President of Corporate Compliance.
...As Vice President of Corporate Compliance, Dr. Malcolm McKay will be responsible for expanding InterMune's Corporate Compliance department and maintaining InterMune's high regulatory standards, including good clinical practices (GCP), current good manufacturing practices (cGMP) and good laboratory practices (GLP).Dr. McKay will report to Dr. Marianne Armstrong, InterMune's Senior Vice President of Global Regulatory Operations and Corporate Compliance.
brings more than 17 years of biopharmaceutical industry experience in the areas of compliance, regulatory, quality assurance and process development to InterMune
.Most recently, Dr. McKay was Vice President of Regulatory Affairs at Cell Genesys, where he was responsible for regulatory and quality assurance.Prior to Cell Genesys, Dr. McKay held senior management positions at Celtrix Pharmaceuticals, COR Therapeutics (now Millennium) and Berlex Biosciences.Earlier in his career, he worked at Triton Biosciences and Abbott Laboratories.Dr. McKay holds a Ph.D. in Biochemistry from the University of London and completed his post-doctoral training at the Medical College of Virginia.